Biotechnology News

January 30, 2013

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Thursday, February 21, 2013 at 3:30 p.m. Central Time to discuss the Company’s operating results for its fourth...

January 30, 2013

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Purdue University researchers receive funds to develop and commercialize innovations.

January 30, 2013

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc. (NASDAQ: LPDX) today announced it has closed its previously announced initial public offering of 5,000,000 shares of common stock at a price to the public of $9.00 per share.

January 30, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

January 30, 2013

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics, today announced the appointment of Clay B. Siegall, Ph.D., co-founder, President, Chief...

January 30, 2013

DANVERS, Mass.--(BUSINESS WIRE)--BioChemics announced today that it has received a patent for a new breakthrough drug delivery technology. This technology called Bifunctional Synthetic Molecule, or BSM, involves covalently bonding two existing...

January 30, 2013

BERLIN--(BUSINESS WIRE)--JPT and The Institute for Medical Immunology at the Charité, Berlin Announce Collaboration on Chronic Fatigue Syndrome (CFS)

January 30, 2013

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Announces Underwritten Sale of Common Stock

January 30, 2013

BISHOPS STORTFORD, England--(BUSINESS WIRE)--Dotmatics, a leading provider of informatics services to the pharmaceutical and biotechnology industries, announced that Redx Pharma have licensed and deployed Dotmatics’ entire suite of solutions.

January 30, 2013

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the publication of a paper authored by a research group under the supervision of Prof. Doron Lancet from the Department of...

January 30, 2013

BEND, Ore.--(BUSINESS WIRE)--Bend Research Inc. (www.bendresearch.com), a leading independent drug-formulation development and manufacturing company, announced today that it...

January 30, 2013

SEATTLE--(BUSINESS WIRE)--Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Monday, February 25, 2012, at 9:00 a.m. ET to review fourth quarter and full year 2012 financial results. Access to the...

January 30, 2013

MALVERN, Pa.--(BUSINESS WIRE)--Ceptaris Announces Publication in JAMA Dermatology of Positive Clinical Results for Mechlorethamine Gel in Early Stage Mycosis Fungoides

January 30, 2013

MORRISVILLE, N.C.--(BUSINESS WIRE)--Don't miss a great opportunity to hear the Oxygen Bio corporate story directly from the President and CFO at the BIO CEO & Investor Conference on Feb. 11 at 9 am

January 30, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and collaborators announced today the publication of complete study results from a Phase I trial with ALN-VSP, a systemically...

January 30, 2013

BEDMINSTER, N.J.--(BUSINESS WIRE)--The Journal of Parenteral and Enteral Nutrition recently published clinical considerations and best-practice recommendations for introducing Gattex® (teduglutide [rDNA origin]) for injection into the management...

January 30, 2013

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced it has received an Issue...

January 30, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer

January 30, 2013

SKANEATELES, N.Y. & WALTHAM, Mass.--(BUSINESS WIRE)--Welch Allyn and EarlySense Ltd. announced today that the companies have entered into a strategic collaboration and distribution agreement.

January 30, 2013

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted...

January 30, 2013

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Partner N3D Could Revolutionize Toxicity Testing

January 30, 2013

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) reported today its sales for the fourth quarter and full year 2012. Fourth quarter and full year 2012 unaudited IFRS consolidated sales     Fourth Quarter   Twelve Months...

January 29, 2013

CAMBRIDGE, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--Genzyme and Isis today announced that the FDA has approved its NDA for KYNAMRO (mipomersen sodium) injection for the treatment of homozygous familial hypercholesterolemia (HoFH).

January 29, 2013

INGELHEIM, Germany--(BUSINESS WIRE)--FDA Advisory Committee Recommends Approval for Boehringer Ingelheim’s Olodaterol* for Maintenance Treatment of COPD

January 29, 2013

BROOMFIELD, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc., today provided an update on a proposed, genetically-targeted clinical trial in atrial fibrillation (“AF”) of the Company’s lead developmental drug, Gencaro.

January 29, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the completion of its previously announced public offering of 15,307,000 shares of common stock at a public offering price of $19.60 per share. In...

January 29, 2013

WASHINGTON--(BUSINESS WIRE)--The 2013 BIO International Convention will feature a program of 800 speakers in 125 sessions across 15 topic areas addressing the latest business opportunities, challenges and innovations in biotech.

January 29, 2013

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex will release its fourth quarter and full year 2012 financial results on Wednesday, March 6, 2013 after the market closes.

January 29, 2013

SAN MATEO, Calif.--(BUSINESS WIRE)--Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced that its distribution of cash in September 2012 primarily will be classified as a return of capital to its stockholders for U.S. Federal...

January 29, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Reports Full-Year and Fourth Quarter 2012 Financial Results and Provides Updates on Key Development Programs

January 29, 2013

SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced the launch of its StabiliT® ERX Bone Cement for use with the...

January 29, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma to present Avastin®-CRLX101 synergy data at the 15th International Symposium on Anti-angiogenic Therapy

January 29, 2013

AUSTIN, Texas & REDWOOD CITY, Calif.--(BUSINESS WIRE)--IMAGINE 2013 kicks off tomorrow in Austin bringing many of the globe’s top interventional cardiologists and vascular surgeons together to learn about the medical game-changing Ocelot...

January 29, 2013

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, is pleased to announce that Paragon Bioservices has acquired both the MaxCyte VLX® Large Scale Transfection System and...

January 29, 2013

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) will report its fourth quarter and year 2012 financial results on Tuesday, February 12, 2013, after the close of financial markets.

January 29, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems has been granted a design patent related to the cartridges for the Company's T2Candida assay, which diagnoses species-specific Candida in under three hours.

January 29, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (OTC: OVSC), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive...

January 29, 2013

WOBURN, Mass.--(BUSINESS WIRE)--CryoXtract, a leader in unique automation solutions for optimizing frozen biological samples, entered into an agreement with GC biotech B.V. to distribute in the Benelux countries and Germany.

January 29, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--CUBIST TO PRESENT AT FEBRUARY INVESTOR CONFERENCES

January 29, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron earns $10 million milestone payment from collaboration partner Celgene Corporation as novel compound ACE-536 enters phase 2 clinical trial for MDS.

January 29, 2013

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies CSO discusses unique approaches to improving ophthalmic therapies using transformative drug development and manufacturing platform.

January 29, 2013

BOSTON--(BUSINESS WIRE)--OncoPep has initiated a Phase 1/2a clinical trial to evaluate PVX-410, a multi-peptide cancer vaccine, in patients with smoldering multiple myeloma, an asymptomatic precursor to multiple myeloma.

January 29, 2013

LONDON--(BUSINESS WIRE)--New research study on the World Microbiology Market drawn up by Venture Planning Group has been recently published at MarketPublishers.con

January 29, 2013

LONDON--(BUSINESS WIRE)--New research report on the Inherited Orphan Blood Disorders Therapeutics Market drawn up by GBI Research has been recently published at MarketPublishers.com

January 29, 2013

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Holyoke Medical Center is expanding its relationship with the company to include eClinicalWorks Care Coordination Medical Record™ (CCMR) for advancing its Accountable Care Organization-related goals.

January 29, 2013

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE): ($ in millions, except per share amounts)                 Fourth-Quarter Full-Year   2012         2011(5) Change   2012     2011(5) Change Reported Revenues $ 15,068 $ 16,141 (7 %) $ 58,986 $ 65...

January 29, 2013

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) today announced positive preliminary results from the first of two Phase 3 trials of tavaborole, its topical anti-fungal for onychomycosis, a fungal infection of the nail...